Literature DB >> 6407770

Reversible microangiopathic hemolytic anemia after mitomycin C.

D J Perry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6407770     DOI： 10.1007/BF00255769

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  3 in total

1.  Hemolytic-uremic syndrome associated with mitomycin therapy.

Authors:  M D Pavy; E L Wiley; M D Abeloff
Journal:  Cancer Treat Rep       Date:  1982-03

2.  Mitomycin-induced hemolytic uremic syndrome: case presentation and review of literature.

Authors:  S J Rabadi; J D Khandekar; H J Miller
Journal:  Cancer Treat Rep       Date:  1982-05

3.  Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma.

Authors:  B R Kressel; K P Ryan; A T Duong; J Berenberg; P S Schein
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.